Navigation Links
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
Date:4/25/2013

BALA CYNWYD, Pa., April 25, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PROLOR Biotech, Inc. ("PROLOR" or the "Company") (NYSE- PBTH) relating to the proposed acquisition by OPKO Health, Inc. ("OPKO").

Under the terms of the transaction, PROLOR shareholders will receive only 0.9951 shares of OPKO stock for each share of PROLOR stock they own. The transaction values PROLOR stock at approximately $7.025 per share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PROLOR for not acting in the Company's shareholders' best interests in connection with the sale process. The transaction may undervalue the Company as an analyst has set a $12.00 per share price target on PROLOR stock. In addition, it has been reported that Deerpath Capital has indicated that the Company is worth more than $10.00 per share.

If you own shares of PROLOR stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/571-pbth-prolor-biotech-inc.html, by calling toll free 877-LEGAL-90.

Attorney advertising. Prior results do not guarantee a similar outcome.


'/>"/>
SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
10. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
11. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , ... December 06, 2016 , ... ... custom industrial automation and IT solutions, today announced the company has successfully completed ... delivered professionally executed automation and control systems integration services to leading companies in ...
(Date:12/6/2016)... (PRWEB) , ... December 06, ... ... a Great Point Partners ("GPP") portfolio company, today announced it has acquired ... previously a subsidiary of Chiltern International and focuses on clinical trial drug ...
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Creative Medical ... Kesari , MD, PhD, FANA, FAAN to the Company,s ... neurology and clinical trials to assist the Company,s clinical ... stroke. The AmnioStem product is a universal donor stem cell ... activity in animal models of stroke 1 .  ...
(Date:12/6/2016)... MENLO PARK, Calif. , Dec. 6, 2016 ... of up to $150 million from the National ... Infectious Diseases and the Division of AIDS (NIAID-DAIDS) ... microbicides and other non-vaccine pre-exposure (PreP) agents. Under ... suite of preclinical product development services for candidate ...
Breaking Biology Technology:
(Date:12/6/2016)... WARSAW, Ind. , Dec. 6, 2016  Zimmer Biomet ... that it has priced an offering of €500.0 million principal ... €500.0 million principal amount of its 2.425% senior unsecured notes ... is expected to occur on December 13, 2016, subject to the ... on an annual basis. ...
(Date:12/5/2016)... Dec. 5, 2016  The Office of Justice ... "Can CT Scans Enhance or Replace Medico Legal ... of supporting or replacing forensic autopsies with postmortem ... In response to recommendations made by ... using CT scans as a potential component of ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
Breaking Biology News(10 mins):